Acute response to rapid iloprost inhalation using the Breelib™ nebulizer in pulmonary arterial hypertension: the Breelib™ acute study

The Breelib™ nebulizer was designed to reduce iloprost inhalation times for patients with pulmonary arterial hypertension (PAH). In 30 patients with PAH, rapid inhalation of iloprost 2.5 µg using Breelib™ caused significant improvements in invasively measured afterload and cardiac index but not echo...

Descripción completa

Detalles Bibliográficos
Autores principales: Richter, Manuel J., Wan, Jun, Ghofrani, Hossein A., Seeger, Werner, Gall, Henning, Rieth, Andreas, Tello, Khodr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6740066/
https://www.ncbi.nlm.nih.gov/pubmed/31588353
http://dx.doi.org/10.1177/2045894019875342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6740066/
https://www.ncbi.nlm.nih.gov/pubmed/31588353
http://dx.doi.org/10.1177/2045894019875342

Ejemplares similares